Consistent with these beneficial changes in adipose tissue inflammation and lipid homeostasis, Ntn1Δmac mice showed improved insulin sensitivity compared to WT mice, suggesting that macrophage-specific targeting of netrin-1 may hold promise for the treatment of chronic inflammation and metabolic dysfunction in obesity. This evidence concerns the gene NTN1 and obesity due to melanocortin 4 receptor deficiency.